Therapy Areas: Oncology
FDA grants rare paediatric disease designation to RedHill's opaganib
...
GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio
9 June 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has entered an agreement to acquire Nuvalent Inc (NASDAQ:NUVL), a Boston-based clinical-stage biopharm...
Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours
9 June 2026 - Adcentrx Therapeutics, a California-based clinical-stage biotechnology company advancing Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases,...
Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma
...
OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance
8 June 2026 - Chinese biotechnology company OriCell Therapeutics Holdings Limited announced on Sunday that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from...
Owkin to build AI agents as part of K Pro collaboration with Sanofi
5 June 2026 - Agentic AI company Owkin announced on Friday that it has entered into a multi-year collaboration with French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) to co-develo...